California Public Employees Retirement System Has $67.86 Million Position in Kenvue Inc. $KVUE

California Public Employees Retirement System boosted its position in Kenvue Inc. (NYSE:KVUE - Free Report) by 4.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,242,423 shares of the company's stock after acquiring an additional 123,636 shares during the period. California Public Employees Retirement System owned 0.17% of Kenvue worth $67,864,000 as of its most recent SEC filing.3 Smart Defensive Stocks for an Uneasy MarketOther hedge funds and other institutional investors also recently made changes to their positions in the company. Atria Wealth Solutions Inc. lifted its position in shares of Kenvue by 48.0% during the 1st quarter. Atria Wealth Solutions Inc. now owns 27,022 shares of the company's stock worth $648,000 after buying an additional 8,765 shares in the last quarter. AlphaCore Capital LLC bought a new position in shares of Kenvue in the first quarter worth approximately $115,000. Townsquare Capital LLC raised its position in Kenvue by 8.6% during the first quarter. Townsquare Capital LLC now owns 31,273 shares of the company's stock valued at $750,000 after purchasing an additional 2,477 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in shares of Kenvue by 39.2% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 29,030 shares of the company's stock worth $696,000 after acquiring an additional 8,178 shares during the last quarter. Finally, Frank Rimerman Advisors LLC purchased a new stake in Kenvue during the 1st quarter valued at about $444,000. 97.64% of the stock is owned by institutional investors. Analysts Set New Price TargetsKVUE has been the subject of a number of research reports. Redburn Partners set a $22.00 price target on shares of Kenvue in a research note on Friday, September 26th. Barclays lifted their target price on Kenvue from $17.00 to $18.00 and gave the stock an "equal weight" rating in a report on Monday, November 10th. Johnson Rice reissued a "neutral" rating on shares of Kenvue in a report on Tuesday, October 28th. Weiss Ratings restated a "hold (c-)" rating on shares of Kenvue in a research note on Tuesday, October 14th. Finally, Canaccord Genuity Group reiterated a "hold" rating and set a $15.00 target price (down from $26.00) on shares of Kenvue in a research report on Wednesday, October 29th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and thirteen have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $20.23.Sticker Shock: Why Kimberly-Clark's Sell-Off Is an OverreactionCheck Out Our Latest Stock Analysis on KenvueKenvue Stock PerformanceShares of NYSE:KVUE opened at $16.78 on Tuesday. The company has a current ratio of 0.98, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17. The company has a market capitalization of $32.15 billion, a price-to-earnings ratio of 22.38 and a beta of 0.59. The firm's 50-day moving average is $16.10 and its 200 day moving average is $19.24. Hold Ratings, High Rewards? 3 Stocks That Could Defy ExpectationsKenvue (NYSE:KVUE - Get Free Report) last announced its earnings results on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.01. The business had revenue of $3.76 billion during the quarter, compared to analyst estimates of $3.83 billion. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The company's revenue for the quarter was down 3.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.28 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Research analysts predict that Kenvue Inc. will post 1.14 EPS for the current year. Kenvue Dividend AnnouncementThe firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th were given a $0.2075 dividend. This represents a $0.83 annualized dividend and a yield of 4.9%. The ex-dividend date of this dividend was Wednesday, November 12th. Kenvue's dividend payout ratio is 110.67%. Kenvue Profile (Free Report)Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.See AlsoFive stocks we like better than KenvueBasic Materials Stocks InvestingWhat Dollar Tree’s Surge and Home Depot’s Slide Say About Consumer Health3 Home Improvement Stocks that Can Upgrade Your Portfolio3 Stocks Most Likely to Split in 2026Why Are These Companies Considered Blue Chips?ChargePoint's Comeback Story: Why This EV Stock Is Charging Up AgainThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Kenvue Right Now?Before you consider Kenvue, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here